Cystic Fibrosis impacts approximately 1 in every 3,500 births, with around 70,000 affected individuals globally, and 31,000 in the United States alone. Those with the condition experience the development of dense, adhesive mucus in their lungs, making them prone to infections. Over time, this leads to inflammation and a gradual decline in lung function.
DelveInsight estimated that 67,000 individuals were afflicted by cystic fibrosis in 2022. The increase in cystic fibrosis cases underscores the urgent need for innovative therapies as medical advancements have prolonged the lives of cystic fibrosis patients, creating a greater demand for treatments to manage the con...
